FDA Challenge In Regulating Esoteric Nanotechnology Discussed At FDLI
This article was originally published in The Rose Sheet
Executive Summary
FDA recognizes the impact nanotechnology is making in cosmetics, food and dietary supplements, but says it likely is years away from proposing regulations for its use
You may also be interested in...
Advisory Committee Split On Whether FDA Should Draft Nanotech Guidance
FDA currently lacks information needed to draft effective guidance for the development of nanotechnology-derived drug applications, according to a majority of FDA's Pharmaceutical Science and Clinical Pharmacology advisory committee
Advisory Committee Split On Whether FDA Should Draft Nanotech Guidance
FDA currently lacks information needed to draft effective guidance for the development of nanotechnology-derived drug applications, according to a majority of FDA's Pharmaceutical Science and Clinical Pharmacology advisory committee
Bill Takes Small Step Toward More Nanotech Research, Commercialization
Congress is recognizing the need for direction in nanotechnology research, but researchers and consumer safety advocates say more is needed to spur further nanotech commercialization and adequately protect the public from potential dangers